Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,020,342
+$220,797 QoQ
Shares Held
208,486
+22.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#602
of 2,821 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2025CallValue
$1,618,500
CallShares
65,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AlphaCore Capital LLC holds $65,400,986 across 13 Drug Manufacturers - General names. PFE ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,692 | $16,422,596 | |
| 2 | JNJ |
Johnson & Johnson
|
50,226 | $12,755,897 | |
| 3 | ABBV |
AbbVie Inc.
|
45,476 | $11,443,580 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,249 | $6,585,496 | |
| 5 | PFE |
Pfizer Inc
This page
|
208,486 | $5,020,342 | |
| 6 | AMGN |
Amgen Inc
|
13,140 | $4,758,256 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
46,389 | $2,672,934 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
16,707 | $2,110,762 |
All Filings in PFE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,020,342 | 208,486 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,799,545 | 170,924 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,618,500 | 65,000 | Call | Sole | 2026-02-05 | |
| 2025-12-31 | $4,092,763 | 164,368 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,423,059 | 134,343 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,121,557 | 87,523 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,779,045 | 70,207 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,596,973 | 60,195 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $1,598,124 | 55,222 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,527,624 | 54,597 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,993,005 | 71,820 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,100,892 | 72,973 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,075,214 | 62,563 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,204,688 | 60,106 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,072,020 | 26,275 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,313,025 | 25,625 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,046,607 | 23,917 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,022,122 | 19,495 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $855,343 | 16,522 | Shares | Sole | 2022-05-04 | |
| 2020-03-31 | $242,286 | 7,423 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||